Piezo1high/CD133+CD44+ colon tumors are associated with advanced clinical stage, suggesting that the presence of Piezo1high/CD133+CD44+ CCSCs is a potential prognostic marker, and Piezo1 is a promising target for the selective elimination of CCSCs. Here, PROM1 is linked to colonic neoplasm.